Whalley D - Search Results

1

The psychometric properties of the psoriasis disability index in United States patients.

Nijsten T, Whalley D, Gelfand J, Margolis D, McKenna SP, Stern RS. Nijsten T, et al. Among authors: whalley d. J Invest Dermatol. 2005 Oct;125(4):665-72. doi: 10.1111/j.0022-202X.2005.23775.x. J Invest Dermatol. 2005. PMID: 16185264 Free article.

2

The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrument.

de Jong Z, van der Heijde D, McKenna SP, Whalley D. de Jong Z, et al. Among authors: whalley d. Br J Rheumatol. 1997 Aug;36(8):878-83. doi: 10.1093/rheumatology/36.8.878. Br J Rheumatol. 1997. PMID: 9291857

3

Quality of life in rheumatoid arthritis.

Whalley D, McKenna SP, de Jong Z, van der Heijde D. Whalley D, et al. Br J Rheumatol. 1997 Aug;36(8):884-8. doi: 10.1093/rheumatology/36.8.884. Br J Rheumatol. 1997. PMID: 9291858

4

The development and testing of the well-being index for surgical patients (WISP).

McKenna SP, Doward LC, Whalley D. McKenna SP, et al. Among authors: whalley d. Qual Life Res. 1998 Feb;7(2):167-73. doi: 10.1023/a:1008861627541. Qual Life Res. 1998. PMID: 9523498

5

Measuring quality of life in patients with depression or anxiety.

Whalley D, McKenna SP. Whalley D, et al. Pharmacoeconomics. 1995 Oct;8(4):305-15. doi: 10.2165/00019053-199508040-00005. Pharmacoeconomics. 1995. PMID: 10155672 Review.

6

The development of a quality of life instrument for use with post-menopausal women with urogenital atrophy in the UK and Sweden.

McKenna SP, Whalley D, Renck-Hooper U, Carlin S, Doward LC. McKenna SP, et al. Among authors: whalley d. Qual Life Res. 1999 Aug;8(5):393-8. doi: 10.1023/a:1008884703919. Qual Life Res. 1999. PMID: 10474280

7

Application of a disease-specific, quality-of-life measure (QoL-AGHDA) in growth hormone-deficient adults and a random population sample in Sweden: validation of the measure by rasch analysis.

Wirén L, Whalley D, McKenna S, Wilhelmsen L. Wirén L, et al. Among authors: whalley d. Clin Endocrinol (Oxf). 2000 Feb;52(2):143-52. doi: 10.1046/j.1365-2265.2000.00899.x. Clin Endocrinol (Oxf). 2000. PMID: 10671940

8

The development and psychometric assessment of the Turkish version of the Nottingham Health Profile.

Kücükdeveci AA, McKenna SP, Kutlay S, Gürsel Y, Whalley D, Arasil T. Kücükdeveci AA, et al. Among authors: whalley d. Int J Rehabil Res. 2000 Mar;23(1):31-8. doi: 10.1097/00004356-200023010-00004. Int J Rehabil Res. 2000. PMID: 10826123

9

Assessment of biotechnology drugs: what are the issues?

McKenna SP, Whalley D. McKenna SP, et al. Among authors: whalley d. Health Policy. 1999 Nov;49(3):195-7. doi: 10.1016/s0168-8510(99)00055-x. Health Policy. 1999. PMID: 11009833 No abstract available.

10

International development of the Quality of Life in Depression Scale (QLDS).

McKenna SP, Doward LC, Kohlmann T, Mercier C, Niero M, Paes M, Patrick D, Ramirez N, Thorsen H, Whalley D. McKenna SP, et al. Among authors: whalley d. J Affect Disord. 2001 Mar;63(1-3):189-99. doi: 10.1016/s0165-0327(00)00184-1. J Affect Disord. 2001. PMID: 11246095

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters